Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811 (Q46260247)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811 (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

adaptive radiation therapy

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Michael J Zelefsky

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

7

object named as

Eric Small

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

William Kevin Kelly

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Aymen Elfiky

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

San-San Ou

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Jeff Bogart

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Cancer Leukemia Group B

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

language of work or name

0 references

publication date

1 December 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

113

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

3137-3145

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

21 January 2018

Neoadjuvant estramustine and etoposide followed by concurrent estramustine and definitive radiotherapy for locally advanced prostate cancer: feasibility and preliminary results

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

21 January 2018

The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Orchiectomy versus goserelin and flutamide in the treatment of newly diagnosed metastatic prostate cancer. Analysis of the criteria of evaluation used in the European Organization for Research and Treatment of Cancer--Genitourinary Group Study 30853

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Extended Experience With Radical Prostatectomy for Clinical Stage T3 Prostate Cancer: Outcome and Contemporary Morbidity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in prostate cancer. Analysis of 874 patients treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer. Canadian Urologic Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Paclitaxel, estramustine phosphate, and carboplatin in patients with advanced prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol 92-02.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I trial of weekly docetaxel with concurrent three-dimensional conformal radiation therapy in the treatment of unfavorable localized adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23910

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.23910

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

release_mooirafg5zdzhf6dk6uhyhhmme

1 reference

https://api.fatcat.wiki/v0/release/mooirafg5zdzhf6dk6uhyhhmme

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18989865%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46260247&oldid=2186406643"